Data as of:
brimindinvest.com / compare / krc-vs-bxpLIVE
KRC
Kilroy Realty Corporation · Real Estate - Office
$34.83
+1.19% this month
VERSUS
COMPARE
BXP
BXP, Inc. (formerly Boston Properties) · Real Estate - Office
$59.20
-7.56% this month
Comparison scoreboard
BXP LEADS 4/5
AI Scorei
KRC 24.6
BXP ✓26.3
1Y Returni
KRC ✓-14.08%
BXP -17.47%
Fwd P/Ei
KRC 68.36
BXP ✓28.31
Target Up.i
KRC +9.57%
BXP ✓+28.62%
Op. Margini
KRC 23.99%
BXP ✓28.75%
Metrics last refreshed: 10/17/2026
Quick take

KRC vs BXP Stock Comparison: AI Score, Valuation, Performance and Upside

ShareXLinkedInRedditFacebookWhatsApp

KRC (Kilroy Realty) and BXP are both premier office REITs navigating the post-COVID office demand reset — Kilroy is the West Coast specialist expanding into life science with a technology-market tenant base, while BXP is the largest U.S. office REIT with trophy gateway city properties in Boston, New York, San Francisco, Washington DC, and Los Angeles — both facing unprecedented office vacancy challenges especially in San Francisco.

KRC vs BXP is West Coast technology and life science office REIT with creative market positioning (Kilroy's San Diego biotech, LA media, Seattle tech exposure with sustainability leadership and life science pivot — managing West Coast tech employment cyclicality) versus the largest U.S. office REIT with trophy gateway city assets (BXP's iconic Class A buildings in Boston, New York, and San Francisco serving Fortune 500 and financial sector tenants — flight-to-quality beneficiary with San Francisco exposure as primary risk).

Live analysis · updated 10/17/2026

BXP holds the edge across 4 of 5 key metrics in this comparison. KRC has delivered stronger 1-year price return (-14.08% vs -17.47%), though BXP has the better forward P/E setup (28.31x vs 68.36x for KRC). BXP leads on both revenue growth (3.70%) and operating margin (28.75%), suggesting a stronger fundamental setup on both dimensions. Analyst consensus implies meaningfully more upside for BXP (+28.62%) than for KRC (+9.57%).

Normalized 1Y performance
KRC
BXP
Recent returns
KRC
BXP
Analyst price targets & sentiment

Human Wall Street analysts' price targets, typically implying a ~12-month view — a separate signal from this site's own AI Prediction Signal further down the page, which is a 5-/30-day machine-learning forecast based on price history alone.

KRC
Price target range
analyst mean$40.07
current price$34.83
+9.6% upside to analyst mean
BXP
Price target range
analyst mean$75.95
current price$59.20
+28.6% upside to analyst mean
Who should consider this stock?
KRC may suit investors who:
  • Want West Coast premium office exposure with a growing life science component that is more defensive than pure-play technology office
  • Value Kilroy's sustainability leadership (LEED, carbon neutrality) as increasingly important for ESG-focused corporate tenants in lease decisions
  • Believe the West Coast technology market will recover and that KRC's San Diego life science exposure provides meaningful portfolio diversification
BXP may suit investors who:
  • Want the largest, most liquid U.S. office REIT with trophy Class A assets in gateway cities that should be flight-to-quality beneficiaries as companies consolidate into fewer, better offices
  • Believe Boston and New York office markets (BXP's strongest markets) will recover faster than West Coast tech markets, providing earnings stability
  • See BXP's scale, development expertise, and trophy asset portfolio as providing superior competitive positioning in a structurally challenging office environment
Performance & AI score
Performance & AI score
MetricKRCBXP
AI scorei24.626.3
AI ranki#2968#2488
Latest closei$34.83$59.20
1M returni+1.19%-7.56%
3M returni-13.47%-15.25%
6M returni+10.75%+1.98%
1Y returni-14.08%-17.47%
$10,000 invested — hypothetical growth (dividends reinvested)

How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?

$10,000 invested — hypothetical growth (dividends reinvested)
PeriodKRCBXP
1Y ago$8.61K (-13.9%)
started 2025-10-16
$8.41K (-15.9%)
started 2025-10-16
5Y ago$5.07K (-49.3%)
started 2021-10-18
$7.64K (-23.6%)
started 2021-10-18
10Y ago$4.93K (-50.7%)
started 2016-10-17
$10.1K (+1.0%)
started 2016-10-17

Hypothetical — past performance does not guarantee future results.

Valuation & upside potential
Valuation & upside potential
MetricKRCBXP
Market capi$4.29B$10.68B
Trailing P/Ei25.5731.75
Forward P/Ei68.3628.31
Price/SalesiN/AN/A
EV/Revenuei8.088.73
Analyst targeti$40.07$75.95
Target upsidei+9.57%+28.62%
Growth, profitability & risk
Growth, profitability & risk
MetricKRCBXP
Revenue growthi-6.00%3.70%
Earnings growthi-70.20%-23.20%
EPS growthi-70.20%-23.20%
FCF margini+65.61%+27.60%
Operating margini23.99%28.75%
Profit margini15.47%9.30%
ROIC proxyi3.43%5.31%
Return on equityi3.43%5.31%
Dividend yieldi5.96%4.74%
Payout ratioi151.05%150.54%
Dividend growth streakiN/ANo increase yet
Betai1.151.05
Debt/equityi85.62211.63
Current ratioi1.100.51
Quick ratioi1.030.45
Correlation

Over the past year, KRC and BXP have moved strongly in the same direction (correlation of 0.74), based on daily returns.

1Y
0.74
-1.0+1.0
5Y
0.85
-1.0+1.0
10Y
0.84
-1.0+1.0
Drawdown & downside risk

Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.

1Y risk snapshot
KRC max drawdowni36.25%
BXP max drawdowni31.54%
KRC max wkly dropi11.66%
BXP max wkly dropi9.32%
5Y risk snapshot
KRC max drawdowni66.97%
BXP max drawdowni62.57%
KRC max wkly dropi17.39%
BXP max wkly dropi15.64%
10Y risk snapshot
KRC max drawdowni70.48%
BXP max drawdowni63.59%
KRC max wkly dropi25.74%
BXP max wkly dropi29.95%
Performance metrics by period
Performance metrics by period
PeriodMetricKRCBXP
1YGrowthi-13.89%-15.90%
CAGRi-13.91%-15.92%
Volatilityi28.18%27.44%
Sharpe ratioi-0.55-0.66
Sortino ratioi-0.75-0.87
Max drawdowni36.25%31.54%
Current drawdowni19.89%20.57%
Avg drawdowni17.08%13.91%
Ulcer Indexi19.59%16.13%
Max daily dropi6.87%6.54%
Max wkly dropi11.66%9.32%
5YGrowthi-49.29%-38.00%
CAGRi-12.72%-9.13%
Volatilityi34.14%33.16%
Sharpe ratioi-0.36-0.26
Sortino ratioi-0.51-0.36
Max drawdowni66.97%62.57%
Current drawdowni55.85%46.25%
Avg drawdowni47.33%37.49%
Ulcer Indexi50.27%40.16%
Max daily dropi8.88%7.70%
Max wkly dropi17.39%15.64%
10YGrowthi-50.72%-33.39%
CAGRi-6.83%-3.98%
Volatilityi31.66%32.31%
Sharpe ratioi-0.21-0.10
Sortino ratioi-0.29-0.15
Max drawdowni70.48%63.59%
Current drawdowni60.55%47.72%
Avg drawdowni33.53%27.00%
Ulcer Indexi41.13%32.51%
Max daily dropi18.50%17.20%
Max wkly dropi25.74%29.95%
AI Prediction Signali
Members only
Next 5 trading days
KRC
+2.8%BUY
BXP
+1.1%HOLD
Next 30 trading days
KRC
+6.4%BUY
BXP
+3.2%HOLD

Sign up to unlock AI price predictions

ML model trained on historical prices · 14-day free trial · No credit card required
Business comparison
Business comparison
CategoryKRCBXP
CompanyKilroy Realty CorporationBXP, Inc. (formerly Boston Properties)
SectorReal EstateReal Estate
IndustryREIT - OfficeREIT - Office
Core businessKilroy Realty Corporation is a West Coast-focused office REIT that owns, develops, and acquires premier office and life science properties in San Francisco, Los Angeles, San Diego, and Seattle. Kilroy's portfolio consists of approximately 17 million square feet of stabilized office and life science space. Kilroy has been a leader in sustainable real estate (LEED certification, carbon neutrality commitments) and has aggressively expanded into life science (wet lab, research) facilities, particularly in San Diego's Torrey Pines and San Francisco's Mission Bay submarkets. Kilroy's tenant base includes major technology companies (cloud, software, social media) and biotech/pharma tenants.BXP Inc. (formerly Boston Properties) is the largest publicly traded office REIT in the United States by total market capitalization, owning and developing approximately 54 million square feet of premier office properties in Boston, New York City, San Francisco, Washington DC, and Los Angeles. BXP focuses on Class A trophy properties — the highest-quality, best-located office buildings in each market — serving Fortune 500 companies, major financial institutions, law firms, and government agencies as anchor tenants. BXP's portfolio includes iconic properties like the General Motors Building in New York, 601 Massachusetts Avenue in Washington DC, and Salesforce Tower in San Francisco. BXP renamed itself from Boston Properties to BXP in 2023 to reflect its multi-market identity.
Investor focusInvestors track Kilroy's same-store NOI growth, occupancy rates, life science vs. office tenant mix evolution, development pipeline lease-up progress, and West Coast technology sector employment trends.Investors track BXP's leasing activity (square footage leased, starting rent, lease term), occupancy rates in each market, development pipeline lease-up, and management's commentary on demand trends from large enterprise tenants.
KRC strengths
  • Life science real estate expansion provides diversification from pure-play technology office exposure — San Diego Torrey Pines and San Francisco Mission Bay life science clusters anchor long-term biotech/pharma tenant demand that is more resistant to remote work trends than traditional office
  • Premier West Coast submarkets (SOMA San Francisco, Westside LA, UTC San Diego) command above-average rents from technology and media tenants willing to pay for location quality
  • Sustainability leadership (LEED certification, carbon neutrality) is increasingly important to ESG-focused corporate tenants who use sustainability ratings as criteria in office selection
BXP strengths
  • Trophy Class A assets in gateway cities command premium rents and retain tenants better than commodity office — in a flight-to-quality environment (post-COVID, companies are consolidating into fewer, better offices), BXP's best-in-class buildings are the beneficiaries
  • Boston and New York are the strongest U.S. office markets — both cities have significant life science and financial services demand that partially offsets technology sector softness; Boston's Kendall Square biotech cluster provides BXP a natural life science tenant base
  • Scale provides development and capital market advantages — BXP's balance sheet and development expertise (having developed iconic buildings for decades) provides competitive advantages in winning development opportunities
Risks to watch — KRC
  • West Coast technology sector slowdown directly impacts Kilroy's tenant demand — San Francisco and Seattle office markets are heavily exposed to technology sector employment cycles; tech layoffs (2022-2023) and remote/hybrid work adoption reduced office utilization and lease renewal activity
  • San Francisco office market vacancy rates have reached unprecedented levels (25%+) — San Francisco's office market is the most challenged major U.S. office market; Kilroy's Mission Bay and SOMA San Francisco properties face meaningful uncertainty at lease expiration
  • Development projects begun during pre-COVID demand environment may require longer lease-up periods — Kilroy's development pipeline was designed for a pre-COVID leasing environment; post-COVID lease-up timelines are longer than historical norms
Risks to watch — BXP
  • San Francisco exposure is the most significant risk — BXP owns significant San Francisco office space (including Salesforce Tower); the San Francisco office market has the highest vacancy rates in the U.S. and the most uncertain demand recovery timeline
  • Office real estate faces structural demand headwinds from hybrid work — even BXP's trophy Class A assets aren't immune to the reduction in average space per worker that hybrid work creates; long-term space demand per tenant may be structurally lower
  • High interest rate environment compresses REIT valuations and increases refinancing costs — office REITs are heavily leveraged; rising interest rates have increased BXP's debt service costs and compressed the valuation multiples investors apply to its earnings
Frequently asked questions
What happened: San Francisco's office market was the first and hardest-hit major U.S. office market post-COVID; the city's economy is disproportionately dependent on technology sector employment (social media, cloud computing, fintech, crypto); the technology sector had massive layoffs in 2022-2023 (100,000+ tech jobs eliminated in San Francisco Bay Area); simultaneously, remote and hybrid work became standard practice for technology companies; these two forces simultaneously reduced demand for San Francisco office space while increasing supply via sublease listings from companies reducing their footprints. Current conditions: San Francisco's direct office vacancy rate exceeded 25% by 2023 (compared to approximately 5% pre-COVID); available sublease space (companies listing their leased but unused space for others to rent) added another 5-10% of effective availability; market rents fell significantly from their peaks; major office towers were surrendered to lenders (One Market Plaza, 350 California); building sales at deep discounts to prior valuations set new comparable sales at 40-60% price reductions. Recovery timeline: most office market analysts expect San Francisco recovery to be slow (5-10 years to approach pre-COVID occupancy) given the structural shift in technology work patterns; AI company growth (OpenAI, Anthropic, Scale AI) provides some demand but is not sufficient to offset the scale of departures; some observers argue tech hiring normalization will eventually reabsorb supply; others argue hybrid work is permanent and SF office will structurally underperform other markets. Impact on KRC and BXP: both REITs have significant San Francisco exposure; management teams have generally written down expectations for near-term San Francisco NOI recovery and are not underwriting rapid improvement; the uncertainty around recovery timeline is the primary source of valuation discount for these REITs.
Interactive comparison engine

Compare more than two at a time

This page is a fixed writeup on KRC and BXP. Our comparison engine is the interactive version: load up to five tickers, switch timeframes, and get the correlation, drawdown, and overlap analysis that a static page can't show.

Up to 5 tickers at once

Add three more names beside KRC and BXP, mixing stocks and ETFs in the same table — useful when the real question is which of a whole peer group to own.

Scoreboard verdict

AI score, forward P/E, analyst target upside, operating margin, and revenue growth are scored head-to-head, with a running tally of which ticker leads on how many metrics.

Full risk suite

Volatility, Sharpe and Sortino ratios, maximum, current, and average drawdown, Ulcer Index, and worst single-day and single-week drops across every timeframe.

Correlation heatmap

Pairwise daily-return correlation for every combination, so you can see whether two holdings actually diversify each other or just move together.

Valuation vs profitability

A scatter plot of forward P/E against return on equity, plus drawdown and 30-day rolling volatility charts, to separate what is cheap from what is merely beaten down.

Holdings overlap and CSV export

For ETFs, a top-holdings comparison that exposes hidden overlap between funds. Every comparison exports to CSV for your own spreadsheet work.

Two comparisons a week are free without an account. A 14-day trial removes the limit and adds AI price forecasts, stock rankings, saved watchlists, and the intrinsic value calculator — no credit card required.

Free public comparison

Want deeper AI forecasts?

This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.

More comparisons
Browse all 1,000 comparisons
ShareXLinkedInRedditFacebookWhatsApp